BlackRock Group LTD - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 82 filers reported holding REVANCE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Group LTD ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$145,000
+39.4%
7,007
+9.5%
0.00%
Q3 2016$104,000
+23.8%
6,398
+4.3%
0.00%
Q2 2016$84,000
-22.2%
6,137
-1.4%
0.00%
Q1 2016$108,000
-11.5%
6,224
+74.1%
0.00%
Q4 2015$122,000
+10.9%
3,574
-3.2%
0.00%
Q3 2015$110,000
+26.4%
3,691
+36.2%
0.00%
Q2 2015$87,000
+690.9%
2,709
+332.7%
0.00%
Q4 2014$11,000
-8.3%
6260.0%0.00%
Q3 2014$12,000
-42.9%
6260.0%0.00%
Q2 2014$21,0006260.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders